Massachusetts Rx investigation
Executive Summary
Lilly and Barr join list of companies disclosing subpoenas from the Massachusetts U.S. attorneys office investigation into pricing and reimbursement. Lilly specifies that the March subpoena relates to "pricing and Medicaid reimbursement of company products in Massachusetts." The healthcare fraud unit in Boston appears close to a large settlement with TAP related to marketing and pricing practices (1"The Pink Sheet" April 23, p. 6)